Notch | $15,000,000 | (Oct 2, 2025)
Clarifeye | $4,693,900 | (Oct 2, 2025)
Ankored | $4,000,000 | (Oct 2, 2025)
Certified by Founder
Lodge
Odyssey Therapeutics
start up
United States
- Boston, Massachusetts
- 06/12/2023
- Series C
- $101,000,000
At Odyssey, we are creating next generation precision medicines for patients with cancer and inflammatory diseases with class-leading speed, efficiency and rigor through our highly integrated drug hunting engine.
- Industry Biotechnology Research
- Website https://www.odysseytx.com/
- LinkedIn https://www.linkedin.com/company/odyssey-tx/about/
Prosper AI | $5,000,000 | (Oct 2, 2025)
Gelt | $13,000,000 | (Oct 2, 2025)
Returnalyze | $6,000,000 | (Oct 2, 2025)
Hupside | $1,700,000 | (Oct 2, 2025)
Athernal Bio | $4,718,630 | (Oct 2, 2025)
Price.com | $12,000,000 | (Oct 2, 2025)
Mondoo | $17,500,000 | (Oct 2, 2025)
SolidCore.ai | $4,000,000 | (Oct 2, 2025)
Phaidra | $50,000,000 | (Oct 2, 2025)